These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9155692)

  • 1. Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
    Roberts IS; Burrows C; Shanks JH; Venning M; McWilliam LJ
    J Clin Pathol; 1997 Feb; 50(2):123-7. PubMed ID: 9155692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibroblasts and the progression of crescentic glomerulonephritis.
    Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
    Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy.
    Rocha KB; Soares VA; Viero RM
    Ren Fail; 2004 Jul; 26(4):445-51. PubMed ID: 15462114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytoskeletal proteins differentiates between progressors and non-progressors in treated idiopathic membranous nephropathy.
    Tamimi NA; Stevens PE; O'Donnell PL; Strange PG; Muchaneta-Kubara EC; El Nahas AM
    Exp Nephrol; 1998; 6(3):217-25. PubMed ID: 9639037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial alpha-smooth muscle actin: a prognostic marker in membranous nephropathy.
    Badid C; Desmoulière A; McGregor B; Costa AM; Fouque D; Hadj Aïssa A; Laville M
    Clin Nephrol; 1999 Oct; 52(4):210-7. PubMed ID: 10543323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.
    Mezzano SA; Droguett MA; Burgos ME; Ardiles LG; Aros CA; Caorsi I; Egido J
    Kidney Int; 2000 Jan; 57(1):147-58. PubMed ID: 10620196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats.
    Nakatsuji S; Yamate J; Sakuma S
    Vet Pathol; 1998 Sep; 35(5):352-60. PubMed ID: 9754540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor and crescentic glomerulonephritis.
    El Kossi MM; El Nahas AM
    Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of the interstitial expression of alpha-smooth muscle actin (alpha-SMA) in idiopathic membranous glomerulonephritis and minimal change disease in adults.
    Danilewicz M; Wagrowska-Danilewicz M; Antoszczyk L
    Pol J Pathol; 2000; 51(1):37-43. PubMed ID: 10833902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myofibroblasts and the progression of experimental glomerulonephritis.
    Zhang G; Moorhead PJ; el Nahas AM
    Exp Nephrol; 1995; 3(5):308-18. PubMed ID: 7583053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are CD34+ cells found in renal interstitial fibrosis?
    Okon K; Szumera A; Kuzniewski M
    Am J Nephrol; 2003; 23(6):409-14. PubMed ID: 14566107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of prognostic predictors in idiopathic membranous nephropathy.
    Wu Q; Jinde K; Nishina M; Tanabe R; Endoh M; Okada Y; Sakai H; Kurokawa K
    Am J Kidney Dis; 2001 Feb; 37(2):380-7. PubMed ID: 11157381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibroblasts and the progression of diabetic nephropathy.
    Essawy M; Soylemezoglu O; Muchaneta-Kubara EC; Shortland J; Brown CB; el Nahas AM
    Nephrol Dial Transplant; 1997 Jan; 12(1):43-50. PubMed ID: 9027772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
    Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
    Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction.
    Badid C; Desmouliere A; Babici D; Hadj-Aissa A; McGregor B; Lefrancois N; Touraine JL; Laville M
    Nephrol Dial Transplant; 2002 Nov; 17(11):1993-8. PubMed ID: 12401859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis].
    Chebotareva NV; Bobkova IN; Varshavskiĭ VA; Golitsyna EP; Kozlovskaia LV
    Ter Arkh; 2006; 78(5):17-21. PubMed ID: 16889044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
    Wehrmann M; Bohle A; Bogenschütz O; Eissele R; Freislederer A; Ohlschlegel C; Schumm G; Batz C; Gärtner HV
    Clin Nephrol; 1989 Feb; 31(2):67-76. PubMed ID: 2920470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts.
    Özdemir BH; Özdemir AA; Colak T; Sezer S; Haberal M
    Transplant Proc; 2011 Mar; 43(2):527-9. PubMed ID: 21440751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal pathology in idiopathic membranous nephropathy: a new perspective.
    Troyanov S; Roasio L; Pandes M; Herzenberg AM; Cattran DC
    Kidney Int; 2006 May; 69(9):1641-8. PubMed ID: 16572119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.